Skip to main content
. 2017 Mar 13;56(11):1355–1368. doi: 10.1007/s40262-017-0526-4

Fig. 2.

Fig. 2

Structural model describing the pharmacokinetics of ixazomib. ALAG1 absorption lag time, CL clearance, F absolute bioavailability of an oral ixazomib dose, IV intravenous, KA absorption rate constant, Q 3 first inter-compartmental clearance, Q 4 second inter-compartmental clearance, V 2 central volume of distribution; V 3 volume of distribution of first peripheral compartment, V 4 volume of distribution of second peripheral compartment